Phase 3 Depressive Disorder, Major Clinical Trials

5 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–5 of 5 trials

Recruiting

Phase 3

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Depressive Disorder, Major

Janssen Research & Development, LLC258 enrolled6 locationsNCT07227454

Recruiting

Phase 3

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Depressive Disorder, Major

Janssen Research & Development, LLC752 enrolled205 locationsNCT06559306

Recruiting

Phase 3

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Depressive Disorder, Major

Eli Lilly and Company1,000 enrolled186 locationsNCT07412756

Recruiting

Phase 3

Treating Immuno-metabolic Depression With Anti-inflammatory Drugs

InflammationDepressive Disorder, Major

Amsterdam UMC, location VUmc140 enrolled1 locationNCT05415397

Recruiting

Phase 3

Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Depressive Disorder, Major

Tanta University60 enrolled1 locationNCT06860958